新开源 (300109)

NKY Medical Holdings Ltd.

ASZ

Tags

Plant-Based MeatImmunotherapyInnovative DrugsChemical ProductsChemicalsChemical IndustryGene ConceptPlanned Reduction of HoldingsDispersed ShareholdingChiNext 200 IndexShenzhen ConnectBasic ChemicalsStable Growth IndexCS High Dividend Yield IndexSZSE 700 IndexSSE 700 Growth IndexSZSE 1000 IndexCSI 1000 Growth IndexCSWD Life Sciences IndexNew Virus PreventionRestructuringGene SequencingCOVID-19 TestingShareholding Increase CommitmentJune 2022 Lock-up ExpiryPrecision MedicineGene EditingPublic Health IndexSME Board Innovation IndexCSI 1000 IndexChiNext Basic IndexPrivate Enterprise Development IndexCSI 1000 Growth Innovation IndexCSI 1000 Value IndexCSI All-share Materials Sector Index

K-Line Chart

No K-line data

Company NameBo'ai New Open Source Medical Technology Group Co., Ltd.
Listing Date2010-08-25
Issue Price30Yuan
Registered Capital48470.000510K Yuan
Legal RepresentativeZhang Junzheng
Registered AddressNo. 1888, Wenhua Road (East Section), Bo'ai County, Jiaozuo City, Henan Province, China
IndustryChemical Products
Main BusinessOperating pharmaceutical excipients, polyvinylpyrrolidone (PVP) series products, and vinyl methyl ether/maleic anhydride polymer products.
Company ProfileBo'ai New Open Source Pharmaceuticals Ltd. (BOAI NKY PHARMACEUTICALS LTD.), abbreviated as New Open Source (NKY), stock code: 300109. New Open Source is the first high-tech enterprise in China to research, develop, and produce povidone (PVP) series products. Through nearly 30 years of dedicated progress, it has made significant strides in improving production technology and automation control levels, optimizing the industrial chain structure, expanding production scale, and enhancing quality management standards. It firmly holds the position of No. 1 in China and No. 3 globally in the global PVP industry landscape.

Stock Details

1. Key Indicators

  • Total Shares(W): 48605.00
  • Circulating A-Shares(W): 44968.85
  • Earnings Per Share(RMB): 0.4100
  • Net Assets Per Share(RMB): 7.6580
  • Operating Revenue(W RMB): 95149.95
  • Total Profit(W RMB): 24711.28
  • Net Profit Attributable to Parent(W RMB): 20108.81
  • Net Profit Growth Rate(%): -35.39
  • Weighted Return on Equity(%): 5.4200
  • Operating Cash Flow Per Share(RMB): 0.4400
  • Undistributed Profit Per Share(RMB): 2.1037
  • Capital Reserve Per Share(RMB): 4.2107

2. Main Business

The main business covers:

  • Fine Chemicals
  • Precision Medicine

3. Company Basic Information

  • Company Name: Boai NKY Medical Holdings Ltd.
  • Listing Date: 2010-08-25
  • Industry: Chemicals - Chemical Products
  • Address: No. 1888, East Section of Wenhua Road, Boai County, Jiaozuo City, Henan Province, China
  • Website: www.boai-nky.com
  • Company Profile: The company was established by the overall change of all shareholders of the former NKY Co., Ltd. On April 25, 2009, the shareholders' meeting resolved to convert the audited net assets of 43.9719 million yuan as of December 31, 2008, into 27 million shares at a ratio of 1:0.614, with the remaining 16.9719 million yuan recorded as capital reserve. On May 18, 2009, the Jiaozuo Administration for Market Regulation issued the business license with registration number 410822100001782.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Wuhu Changcheng Guolong Investment Management Co., Ltd. - Wuhu Changqian Investment Center (Limited Partnership) General Legal Person 1394.04 3.10

5. Concept Sectors

  • Gene Concept
  • Immunotherapy
  • Solid-State Battery
  • Innovative Drugs
  • AI Healthcare
  • Margin Trading & Securities Lending
  • Dispersed Shareholding
  • Intended Reduction

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information